Incyte's Jakafi wins FDA nod to treat complication of stem cell transplant
The U.S. Food and Drug Administration on Friday approved Incyte Corp's treatment for acute graft-versus-host disease, a complication from stem cell transplant.
from Reuters: Health News https://reut.rs/30L6JCL
http://bit.ly/2zwRqiM